MassDevice

Medtronic wins expanded FDA approval for OmniaSecure for conduction pacing

Medtronic (NYSE: MDT) announced today that it received FDA approval for an expanded indication for its OmniaSecure defibrillation lead.

Medtronic OmniaSecure™ defibrillation lead is the first lead of its kind to receive FDA approval for conduction system pacing

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, received U.S. Food and Drug Administration (FDA) approval for an expanded indication for the OmniaSecure™ defibrillation lead. Now ...
Medscape

Design Differences Likely Explain Mixed Results in Bundle Branch Pacing Trials

Two multicenter trials drew different conclusions about the value of conduction system relative to biventricular pacing for left bundle branch block in heart failure.
Healio

Cardiac resynchronization therapy displays long-term benefits vs. ICD in HFrEF

Please provide your email address to receive an email when new articles are posted on . Long-term CRT-D use was tied to improved survival and time to adverse events vs. ICD therapy in patients with ...
The American Journal of Managed Care

Conduction System Pacing Falls Short of Biventricular Pacing in HFrEF With LBBB

A 173-patient randomized trial in HFrEF (LVEF ≤35%) with LBBB (QRS ≥130 ms) showed CSP was inferior to BiVP for a hierarchical 12‑month composite endpoint. Worse outcomes with CSP were reflected by an ...
Your Observer

Hosptial joins clinical trial of new heart failure treatment

Sarasota Memorial Hospital is part of a global research effort on an option to traditional cardiac resynchronization therapy.
News Medical

UVA researcher receives Trailblazer R21 Award to improve cardiac resynchronization therapy outcomes

Pacemakers and other implantable devices that restore normal heart rhythms have saved millions of lives. In some patients, a pacemaker or implantable cardioverter defibrillator modified for "cardiac ...
Medscape

Ablate and Pace With Cardiac Resynchronization Therapy for Patients With Reduced Ejection Fraction: Subanalysis of PAVE Study

Presenter: Christopher Fellows, MD, Virginia Mason Medical Center (Seattle, Washington) on behalf of the PAVE Study Group: LV based Cardiac Stimulation Post AV Nodal Ablation E valuation The ...
Healio

4D-guided CRT lead placement improves left ventricular function vs. standard care

Please provide your email address to receive an email when new articles are posted on . 4D model-guided cardiac resynchronization lead placement improved left ventricular function vs. standard care.
Business Wire

EBR Systems’ WiSE CRT System Demonstrates Technical Feasibility of Leadless Left Bundle Branch Area Pacing for Cardiac Resynchronization

SUNNYVALE, Calif.--(BUSINESS WIRE)--EBR Systems, Inc., developer of the world’s only wireless cardiac pacing system for heart failure, today announced the publication of a case report demonstrating ...
PharmiWeb

Landmark Sex-Specific Study Confirms Women Respond Better to Cardiac Resynchronization Therapy

BIOTRONIK’s BIO│WOMEN Study Enrolled 474 Patients Across Eight Countries in Europe and Israel Addressing Critical Gaps as Women Often Remain Undiagnosed and Undertreated in Heart Failure This ...

Medtronic plc: Medtronic OmniaSecure defibrillation lead is the first lead of its kind to receive FDA approval for conduction system pacing

Built for high reliability, world's only lumenless defibrillation lead approved for placement in the left bundle branch area GALWAY, Ireland, March 23, 2026 /PRNewswire/ -- Medtronic plc ...